Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
Subscribe To Our Newsletter & Stay Updated
